Scientific and Economic Challenges in Early Drug Development: Clinical Development Until Proof of Concept
April 03, 2009 – April 03, 200912.00hrs - 16.00hrs Munich, Germany - Innovations- und Gr?nderzentrum Biotechnologie
Clinical Research Funding for Biotech Companies
Michael Kring, Managing Director, High Tech Corporate Services GmbH
Early Clinical Development of New Drugs - Proof of Mechanism
Dr. Matthias Großmann, Vice President and Principal Consultant, PAREXEL
Biomarker and Proof of Concept - Challenges in Oncology
Dr. Udo Kießling, Corporate Vice President & Worldwide Head of Medical Affairs, PAREXEL
Streamlining Biotech Development using International Regulatory Strategy
Dr. Hoss Dowlat, Vice President Drug Development Consulting, PAREXEL
Registration
The meeting is complimentary to members of the biopharmaceutical industry. Lunch will be included. Click here to register.
Location
Innovations- und Gründerzentrum Biotechnologie
(Raum Ellipse 1)
Am Klopferspitz 19
82152 Planegg/Martinsried
Germany
PAREXEL Speakers Bureau
PAREXEL is your reliable source for knowledgeable speakers on issues affecting the pharmaceutical, biological, and medical device industries.
In addition to being leading subject matter experts, members of the PAREXEL team are experienced at delivering lively and compelling presentations to a broad range of audiences. If you need a speaker for an upcoming event, please click here.